Search Results - Renfeng Shan
- Showing 1 - 4 results of 4
-
1
-
2
Beneficial effects of maintaining liver function during hepatic arterial infusion chemotherapy combined with tyrosine kinase and programmed cell death protein-1 inhibitors on the o... by Yongqiang Xiao, Wei Deng, Laihui Luo, Guoqing Zhu, Jin Xie, Yu Liu, Renhua Wan, Wu Wen, Zhigao Hu, Renfeng Shan
Published in BMC Cancer (2024-05-01)Get full text
Article -
3
Hepatic arterial infusion chemotherapy combined with PD-1 inhibitors and tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: A tertiary medical center experience by Laihui Luo, Yongqiang Xiao, Guoqing Zhu, Aihong Huang, Shengjiang Song, Tao Wang, Xian Ge, Jin Xie, Wei Deng, Zhigao Hu, Wu Wen, Haoran Mei, Renhua Wan, Renfeng Shan
Published in Frontiers in Oncology (2022-09-01)Get full text
Article -
4
The safety and efficacy of tyrosine kinase inhibitors and programmed cell death protein- 1 inhibitors combined with HAIC/TACE in the treatment of recurrent unresectable hepatocellu... by Wei Deng, Jin Xie, Tao Wang, Laihui Luo, Guoqing Zhu, Yongqiang Xiao, Jiahao Tao, Liucong Lin, Xian Ge, Wu Wen, Minglong Wang, Bin Yu, Yu Liu, Rongguang Luo, Renhua Wan, Zhigao Hu, Renfeng Shan
Published in BMC Cancer (2025-04-01)Get full text
Article